Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03378765 · ClinicalTrials.gov registry record
Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition
A clinical trial of Obesity and Diabetes, sponsored by Loyola University.
- Active
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT03378765: Active study of Obesity and Diabetes, sponsored by Loyola University.
NCT03378765 is a study of Obesity and Diabetes that is active but no longer recruiting, run by Loyola University. The registered enrollment target is 2,000 participants, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (145% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03378765, a study of Obesity and Diabetes, is active but no longer recruiting, sponsored by Loyola University.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to define associations between gut microbiota, SCFAs and obesity in populations spanning the epidemiologic transition, and explore mechanisms by which these factors may independently and collectively influence the development of obesity. The central hypothesis of this study is that the composition of gut microbiota drives SCFA production which in turn influences obesity risk at the population-level.
Interventions
- BEHAVIORAL Diet and physical activity monitoring
Study Locations (1)
Illinois
- Loyola University Chicago - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2025-03 |
What the registry record for NCT03378765 still lists
NCT03378765 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (145% higher).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Diet and physical activity monitoring is the first listed.
NCT03378765 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03378765 about?
NCT03378765 is a clinical study titled "Gut Microbiota, Short Chain Fatty Acids, and Adiposity Across The Epidemiological Transition". The objective of this study is to define associations between gut microbiota, SCFAs and obesity in populations spanning the epidemiologic transition, and explore mechanisms by which these factors may independently and collectively influence the development of obesity. The central hypothesis of this ...
What is the current status of trial NCT03378765?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2018-01-02. Estimated completion is 2025-03.
What conditions does trial NCT03378765 study?
This clinical trial studies the following conditions: Obesity, Diabetes.
What interventions are being tested in trial NCT03378765?
The interventions under investigation include: Diet and physical activity monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03378765?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03378765 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03378765's enrollment target sits among peer trials
2,000 44th of 1053 higher than 1,008 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI